TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me December 13, 2013